Botulinum Toxin Type A

• BB trial; Effect of botox in Piriformis syndrome Pending
  2023-504427-61-01 Phase IV 1 country Stichting Alrijne Zorggroep
• Botulinumtoxin type A for treatment of Chronic Pelvic Pain Syndrome (CPPS): a phase 3 randomized, double blind, placebo-controlled, multi-ce… Pending
  2023-506372-27-00 Phase III 1 country Ospedale San Raffaele S.r.l.
• DIFFUSION CHARACTERISTICS OF LETIBOTULINUMTOXIN A IN COMPARISON TO ONA AND ABO-BONTA Pending
  2024-511047-26-01 Phase IV 1 country Hamburg University
• Head-to-head comparison of six different botox products voor glabellar frown wrinkles. Pending
  2024-516865-35-01 Phase IV 1 country Stichting Amsterdam UMC
• Efficacy and safety of early intramuscular botulinum toxin injections in the prevention of shoulder deformity in infants with obstetric brac… Pending
  2024-520391-10-01 Phase III 1 country Centre Hospitalier Regional Et Universitaire De Brest
• Botulinum toxin injection after sternotomies to improve scar aspect and impact Pending
  2025-521290-14-00 Phase III 1 country Centre Hospitalier Universitaire De Bordeaux
• Colonic Intramural Injections of Botulin toxin versus placebo to treat fragmented defecation and urgency after restorative total mesorectal … Pending
  2025-524342-96-00 Phase II 1 country UZ Leuven
• Prevention of radiation-induced salivary gland damage by botulinum toxin application in patients with head and neck cancers Pending
  2025-524720-22-00 Phase II 1 country Fakultni Nemocnice Kralovske Vinohrady
• TINNITOX - Botulinum toxin A in tinnitus patients with concurrent bruxism and/or jaw muscle myalgia. A triple blind, randomized, placebo-con… Recruiting
  2024-518256-23-00 Phase III 1 country Sorlandsklinikken
• RHIBOT II - Medium- and long-term efficacy of two ultrasound-guided intra-articular injections of onabotulinumtoxinA (Botox®) combined with … Recruiting
  2024-515028-35-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind tr… Recruiting
  2024-517981-40-00 Phase III 1 country Oslo University Hospital HF
• Botox Treatment for Patients with Hidradenitis Suppurativa: A Within-Person, Randomized, Double-blind, Controlled Study Recruiting
  2024-519946-54-00 Phase IV 1 country Frederiksberg Hospital; Gentofte Hospital
• Mechanisms of action on rectal motility of intrarectal botulinum toxin injections in patients with fecal incontinence - MECA-TOX Recruiting
  2024-515256-21-00 Phase III 1 country Centre Hospitalier Universitaire Rouen
• STROKE-POC Recruiting
  2024-510866-18-00 Phase II 2 countries University Of Antwerp
• Botox injection into the upper esophageal sphincter in inability to belch: a study comparing botox with placebo. Recruiting
  2024-512546-42-00 Phase IV 1 country Algemeen Ziekenhuis Delta
• Safety and efficacy of botulinum toxin A (Botox) in patients with trigeminal neuralgia Recruiting
  2023-504567-17-00 Phase III 1 country Rigshospitalet
• Clinical trial to see the effect and safety of botulinum toxin type A with doses adapted to patients with severe spasticity Recruiting
  2024-517668-51-01 Phase IV 1 country Dra. Nuria Gutierrez Dubón
• The BASIC study Recruiting
  2024-515166-14-00 Phase III 2 countries Norwegian University Of Science And Technolology
• Is botulinum toxin injection better than corticosteroid injection in the management of persistent post-surgical pain Halted
  2024-518954-18-01 Phase IV 1 country Mater Misericordiae University Hospital
• TOXSIALO-TRIAL : Evaluation of the long-term efficacy of the injection of botulinum toxin A into the salivary glands versus scopolamine patc… Ended
  2024-512160-58-00 Phase IV 1 country Hospices Civils De Lyon
• A prospective, randomized, evaluator- and subject blinded, multi-center investigation to assess efficacy and safety of three different dosag… Ended
  2024-512349-17-00 Phase II 2 countries Croma-Pharma GmbH
• A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Parti… Ended
  2022-500568-37-00 Phase III 7 countries Abbvie Deutschland GmbH & Co. KG
• Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa Ended
  2024-517068-43-00 Phase IV 1 country Pirkanmaan hyvinvointialue
• A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults with Upper Limb Spasticity Ended
  2023-509196-16-00 Phase IV 1 country Ipsen Pharma

Showing 1–24 of 27 trials